Trials / Unknown
UnknownNCT01180751
18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial is being conducted to study the use of a radioactive glucose tracer as an imaging test \[Positron Emission Tomography (PET)scan\] in adults who have or are suspected of having cancer and in another group of adults to assess for neurologic conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [18F]-Fluorodeoxyglucose | With each Positron Emission Tomography/Computed Tomography (PET/CT)scan an intravenous administration of radioactive glucose (FDG)is given. This is a weight dependent dosage. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2013-06-01
- Completion
- 2013-12-01
- First posted
- 2010-08-12
- Last updated
- 2013-08-15
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01180751. Inclusion in this directory is not an endorsement.